1047
The hypercalcemia responded to discontinuation of rhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow-up.
 has not recurred in 8 months of follow-up: Effect; discontinuation of rhGH and a single dose of intravenous pamidronate disodium: Treatment; hypercalcemia: Treatment.Disorder; rhGH: Treatment.Drug; pamidronate disodium: Treatment.Drug; intravenous: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 has not recurred in 8 months of follow-up: Effect; discontinuation of rhGH and a single dose of intravenous pamidronate disodium: Treatment; hypercalcemia: Treatment.Disorder; rhGH: Treatment.Drug; pamidronate disodium: Treatment.Drug; intravenous: Treatment.Route